Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer. 

The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.

A team of surgeons and biomedical engineers have shown the use of probe-based near infrared autofluorescence technology helps confirm the identification of parathyroid glands during endocrine surgery

Vanderbilt researchers have developed a computer algorithm that scans electronic health records, or EHRs, to identify patients who meet criteria for lung cancer screening.

Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.

A Vanderbilt study has found that chronic immunotherapy-related complications are more prevalent and persistent than previously shown among melanoma survivors.

Vanderbilt researchers found that T cells become “exhausted” within hours of encountering a tumor, challenging existing ideas about how T cells become dysfunctional.